IMRIS Inc. (IMRSQ) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Specialties industria. El CEO actual es Shalabh Chandra.
IMRSQ tiene fecha de IPO 2023-01-20, 121 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $626.00.
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.
